---
figid: PMC8018312__ONCO-26-e530-g001
figlink: pmc/articles/PMC8018312/figure/onco13702-fig-0002/
number: F2
caption: 'Noncanonical and canonical ER signaling axis. We hypothesized that the partial
  agonist activity of tamoxifen versus the estrogen depletion effect of letrozole
  might explain the observed and widely different clinical responses [, , , ]. We
  also hypothesized that noncanonical ER signaling might be involved, in which MER
  can drive noncanonical ER signaling [, , ]. We constructed a map of the signaling
  pathway that comprises the described interactions, and we considered each of the
  treatment scenarios and responses. We found that our hypothesized mechanisms could
  potentially explain the diverging responses to tamoxifen and letrozole when combined
  with trametinib in a patient with hyperactivated RAS pathway signaling. (Scenario
  1): MER‐driven noncanonical ER signaling and RAS signaling (replicating baseline
  condition of current case report). MER/E2 activates AKT and ER, which leads to cell
  growth. Activation of EGFR subsequently activates RAS/MAPK pathway, which also leads
  to growth signaling (similar to KRAS mutation). (Scenario 2): TMX functions as a
  partial agonist for MER‐driven noncanonical ER signaling. Thus, no inhibitory effect
  is seen on ER signaling. (Scenario 3): Combination treatment with tamoxifen and
  trametinib is not sufficient to halt the cell growth despite the successful inhibition
  of RAS/MEK pathway with trametinib because ER signaling is not adequately reduced
  with tamoxifen. (Scenario 4): Combination of estrogen depletion (mimicking treatment
  with letrozole) and trametinib successfully inhibits both ER and RAS signaling,
  thus leading to the inhibition of cell growth. (Scenario 5): Combination of estrogen
  depletion (mimicking treatment with letrozole) and erlotinib (EGFR inhibitor to
  reduce RAS activation) successfully reduces both ER and RAS signaling, thus leading
  to the inhibition of cell growth. Abbreviations: E2, estradiol; EGF, epidermal growth
  factor; EGFR, epidermal growth factor receptor; ER, estrogen receptor; MAPK, mitogen‐activated
  protein kinase; MEKi, MEK inhibitor; MER, membrane estrogen receptor; pAKT, phospho‐AKT;
  pER, phospho‐ER; TMX, tamoxifen.'
pmcid: PMC8018312
papertitle: 'KRAS‐Mutated, Estrogen Receptor‐Positive Low‐Grade Serous Ovarian Cancer:
  Unraveling an Exceptional Response Mystery.'
reftext: Shumei Kato, et al. Oncologist. 2021 Apr;26(4):e530-e536.
pmc_ranked_result_index: '3519'
pathway_score: 0.8350195
filename: ONCO-26-e530-g001.jpg
figtitle: Noncanonical and canonical ER signaling axis
year: '2021'
organisms:
- Heterocypris barbara
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8018312__ONCO-26-e530-g001.html
  '@type': Dataset
  description: 'Noncanonical and canonical ER signaling axis. We hypothesized that
    the partial agonist activity of tamoxifen versus the estrogen depletion effect
    of letrozole might explain the observed and widely different clinical responses
    [, , , ]. We also hypothesized that noncanonical ER signaling might be involved,
    in which MER can drive noncanonical ER signaling [, , ]. We constructed a map
    of the signaling pathway that comprises the described interactions, and we considered
    each of the treatment scenarios and responses. We found that our hypothesized
    mechanisms could potentially explain the diverging responses to tamoxifen and
    letrozole when combined with trametinib in a patient with hyperactivated RAS pathway
    signaling. (Scenario 1): MER‐driven noncanonical ER signaling and RAS signaling
    (replicating baseline condition of current case report). MER/E2 activates AKT
    and ER, which leads to cell growth. Activation of EGFR subsequently activates
    RAS/MAPK pathway, which also leads to growth signaling (similar to KRAS mutation).
    (Scenario 2): TMX functions as a partial agonist for MER‐driven noncanonical ER
    signaling. Thus, no inhibitory effect is seen on ER signaling. (Scenario 3): Combination
    treatment with tamoxifen and trametinib is not sufficient to halt the cell growth
    despite the successful inhibition of RAS/MEK pathway with trametinib because ER
    signaling is not adequately reduced with tamoxifen. (Scenario 4): Combination
    of estrogen depletion (mimicking treatment with letrozole) and trametinib successfully
    inhibits both ER and RAS signaling, thus leading to the inhibition of cell growth.
    (Scenario 5): Combination of estrogen depletion (mimicking treatment with letrozole)
    and erlotinib (EGFR inhibitor to reduce RAS activation) successfully reduces both
    ER and RAS signaling, thus leading to the inhibition of cell growth. Abbreviations:
    E2, estradiol; EGF, epidermal growth factor; EGFR, epidermal growth factor receptor;
    ER, estrogen receptor; MAPK, mitogen‐activated protein kinase; MEKi, MEK inhibitor;
    MER, membrane estrogen receptor; pAKT, phospho‐AKT; pER, phospho‐ER; TMX, tamoxifen.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - EGF
  - EGFR
  - TMX1
  - HRAS
  - KRAS
  - NRAS
  - MAPK14
  - MAPK3
  - MAPK8
  - MAPK11
  - MAPK13
  - MAPK12
  - MAPK1
  - MAPK9
  - MAPK10
  - MAK
  - PER1
  - Estrogen
  - Tamoxifen
  - Trametinib
  - Erlotinib
genes:
- word: EGF
  symbol: EGF
  source: hgnc_symbol
  hgnc_symbol: EGF
  entrez: '1950'
- word: EGF
  symbol: EGF
  source: hgnc_symbol
  hgnc_symbol: EGF
  entrez: '1950'
- word: EGFR
  symbol: EGFR
  source: hgnc_symbol
  hgnc_symbol: EGFR
  entrez: '1956'
- word: EGFR
  symbol: EGFR
  source: hgnc_symbol
  hgnc_symbol: EGFR
  entrez: '1956'
- word: TMX
  symbol: TMX
  source: hgnc_alias_symbol
  hgnc_symbol: TMX1
  entrez: '81542'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
- word: МАРК
  symbol: MAK
  source: hgnc_symbol
  hgnc_symbol: MAK
  entrez: '4117'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
- word: МАРК
  symbol: MAK
  source: hgnc_symbol
  hgnc_symbol: MAK
  entrez: '4117'
- word: TMX
  symbol: TMX
  source: hgnc_alias_symbol
  hgnc_symbol: TMX1
  entrez: '81542'
- word: pER
  symbol: PER
  source: hgnc_prev_symbol
  hgnc_symbol: PER1
  entrez: '5187'
- word: pER
  symbol: PER
  source: hgnc_prev_symbol
  hgnc_symbol: PER1
  entrez: '5187'
- word: EGF
  symbol: EGF
  source: hgnc_symbol
  hgnc_symbol: EGF
  entrez: '1950'
- word: EGF
  symbol: EGF
  source: hgnc_symbol
  hgnc_symbol: EGF
  entrez: '1950'
- word: EGFR
  symbol: EGFR
  source: hgnc_symbol
  hgnc_symbol: EGFR
  entrez: '1956'
- word: EGFR
  symbol: EGFR
  source: hgnc_symbol
  hgnc_symbol: EGFR
  entrez: '1956'
- word: TMX
  symbol: TMX
  source: hgnc_alias_symbol
  hgnc_symbol: TMX1
  entrez: '81542'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: ΜΑΡΚ
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
- word: ΜΑΡΚ
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: ΜΑΡΚ
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: ΜΑΡΚ
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: ΜΑΡΚ
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: ΜΑΡΚ
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: ΜΑΡΚ
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: ΜΑΡΚ
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: ΜΑΡΚ
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
- word: TMX
  symbol: TMX
  source: hgnc_alias_symbol
  hgnc_symbol: TMX1
  entrez: '81542'
- word: pER
  symbol: PER
  source: hgnc_prev_symbol
  hgnc_symbol: PER1
  entrez: '5187'
- word: TMX
  symbol: TMX
  source: hgnc_alias_symbol
  hgnc_symbol: TMX1
  entrez: '81542'
- word: EGF
  symbol: EGF
  source: hgnc_symbol
  hgnc_symbol: EGF
  entrez: '1950'
- word: EGFR
  symbol: EGFR
  source: hgnc_symbol
  hgnc_symbol: EGFR
  entrez: '1956'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
- word: МАРК
  symbol: MAK
  source: hgnc_symbol
  hgnc_symbol: MAK
  entrez: '4117'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
chemicals:
- word: Estrogen
  source: MESH
  identifier: D004967
- word: Tamoxifen
  source: MESH
  identifier: D013629
- word: Trametinib
  source: MESH
  identifier: C560077
- word: Erlotinib
  source: MESH
  identifier: C400278
diseases: []
figid_alias: PMC8018312__F2
redirect_from: /figures/PMC8018312__F2
figtype: Figure
---
